Display Settings:

Format

Send to:

Choose Destination
    Obstet Gynecol Clin North Am. 2007 Sep;34(3):443-58, xi.

    Blood component therapy in obstetrics.

    Source

    Department of Anesthesiology, University of Colorado Denver Health Sciences Center, 4200 E. 9th Avenue, B-113, Denver, CO 80262, USA. andisamf@msn.com

    Abstract

    Hemorrhage is the leading cause of intensive care unit admission and one of the leading causes of death in the obstetric population. This emphasizes the importance of a working knowledge of the indications for and complications associated with blood product replacement in obstetric practice. This article provides current information regarding preparation for and administration of blood products, discusses alternatives to banked blood in the obstetric population, and introduces pharmacological strategies for treatment of hemorrhage.

    PMID:
    17921009
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk